Back
Humacyte, Inc. Stock Predictions
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
25
HUMA
Humacyte, Inc.
Last Price:
$1.30
Seasonality Move:
-22.55%
7 Day Trial
ALL ACCESS PASS
$
7
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiHumacyte, Inc. Stock Forecast
-
Is Humacyte, Inc. Stock Undervalued?The current Humacyte, Inc. [HUMA] share price is $1.30. The Score for HUMA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
HUMA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Humacyte, Inc. Stock Go Up Next Year?
Data Unavailable
Humacyte, Inc. Stock Rating
Data Unavailable
Humacyte, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
humacyte.com
52-Week Data
52-Week High:
6.77
52-Week Low:
1.09
Prediction Charts
Market Cap:
243.5M
Price in USD:
1.30
Volume:
3.1M
Beta:
1.92
Technical Analysis
SMA50:
1.54
SMA100:
1.72
SMA200:
1.99
52-Wk Change:
-70.65%
Stock Predictions
-
Is Humacyte, Inc. stock public?Yes, Humacyte, Inc. is a publicly traded company.
-
What is the Humacyte, Inc. stock quote today?The Humacyte, Inc. stock price is 1.30 USD today.
-
How to buy Humacyte, Inc. stock online?You can buy Humacyte, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 1.15 | 1.23 | 1.28 | 1.13 |
| Nov-17 | 1.21 | 1.13 | 1.21 | 1.12 |
| Nov-18 | 1.12 | 1.20 | 1.21 | 1.12 |
| Nov-19 | 1.23 | 1.17 | 1.23 | 1.13 |
| Nov-20 | 1.19 | 1.12 | 1.26 | 1.10 |
| Nov-21 | 1.11 | 1.22 | 1.25 | 1.09 |
| Nov-24 | 1.23 | 1.28 | 1.29 | 1.21 |
| Nov-25 | 1.27 | 1.32 | 1.32 | 1.24 |
| Nov-26 | 1.31 | 1.33 | 1.35 | 1.30 |
| Nov-28 | 1.34 | 1.35 | 1.38 | 1.32 |
| Dec-1 | 1.33 | 1.28 | 1.34 | 1.26 |
| Dec-2 | 1.30 | 1.26 | 1.31 | 1.25 |
| Dec-3 | 1.29 | 1.29 | 1.31 | 1.23 |
| Dec-4 | 1.29 | 1.30 | 1.33 | 1.26 |
Humacyte, Inc. Earnings
Data Unavailable
Humacyte, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and a decrease next year of $0.15 per share.
* Humacyte, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.